February 12, 2018 / 12:29 PM / 6 months ago

BRIEF-AVEO Says EUSA Pharma Granted Positive NICE Recommendation For Fotivda

Feb 12 (Reuters) - Aveo Pharmaceuticals Inc:

* AVEO ANNOUNCES EUSA PHARMA GRANTED POSITIVE NICE RECOMMENDATION FOR FOTIVDA® (TIVOZANIB) AS FIRST LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA

* AVEO PHARMACEUTICALS INC - ‍RECOMMENDATION TRIGGERS $2MLN MILESTONE PAYMENT FROM EUSA TO AVEO​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below